BSL Capital

BSL Capital

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

United States, New York

About

BSL Capital is a well known and established VC, which was founded in 2006. The primary office of this VC is located in New York. The fund is located in United States, North America.

The highest number of exits from this fund were in 2014. The fund's activity peaked in 2010. Typical investments for this fund are deals in the range of 10 - 50 millions dollars. The fund typically enters into less than 2 deals annually.

The fund was established by Bennett LeBow. The overall number of key employee in the fund's team is 1.

The average start-up age at the time of investment by this fund is 1 and less. We can highlight the most popular investment areas for this fund, such as Health Care, Innovation Management. In addition, there is 1 more industry where it has achieved success. Signal Genetics is among the most popular portfolio start-up of the fund. The country of its foundation and the country of its most frequent investments coincides - United States.

The fund usually invests in rounds together with 1-2 others. Besides BSL Capital, start-ups are typically funded by Myeloma Institute for Research and Therapy UAMS. The fund often co-invests with Myeloma Institute for Research and Therapy UAMS.

Year Founded

2006

Fund Activity

Not operative

Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: bslcapital.com; User name format in descending order of probability: first_initial last

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Investments per Year [average amount of rounds in which fund participates each year]

<1

Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

50.0% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]

x4

Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

0.2 years

Funds Investing in Previous
Rounds

Myeloma Institute for Research and Therapy UAMS

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: